Searchable abstracts of presentations at key conferences in endocrinology

ea0049s19.3 | How to incorporate the new guidelines for thyroid cancer in my clinical practice | ECE2017

Dynamic risk stratification in low-risk vs high-risk patients

Melo Miguel

In recent years, an increasing interest in an individualized approach for the care of patients with differentiated thyroid cancer has occurred. The cornerstone of individualized treatment is the existence of a proper risk stratification system that supports physicians’ options regarding the treatment and follow-up of patients. Considering that the initial risk stratification systems account for only about 15–20% of the variability in the outcome they are trying to pr...

ea0014p386 | (1) | ECE2007

Congenital hypothyroidism – results of a protocol implemented &br;1993–2006

Melo Miguel , Buchanan Charles

Introduction: A new Regional Paediatric Endocrine Service was established in 1993 which implemented a protocol for Congenital Hypothyroidism (CH) management. Its aim is to confirm the diagnosis, establish aetiology and start treatment within 48 hours after the result of the screening test.Objective: To audit the results of this protocol.Methods: Case note and laboratory data review for all Neonates referred since 1993 after a posit...

ea0081yi9 | Young Investigator Awards | ECE2022

Acute kidney injury: a strong risk factor for hypoglycaemia in hospitalized patients with type 2 Diabetes

Carreira Ana , Castro Pedro , Mira Filipe , Melo Miguel , Paiva Isabel , Ribeiro Pedro , Santos Lelita

Introduction: Acute Kidney Injury (AKI) is highly prevalent during hospitalization of patients with type 2 diabetes (T2D), and has been associated with increased risk of hypoglycaemia in Intensive Care Units. However, this association in non-critically ill patients is less clear and evidence on the impact of AKI’s severity and duration on hypoglycaemia is lacking.Objectives: To assess the impact of AKI and its severity and duration on the risk of hy...

ea0081ep769 | Pituitary and Neuroendocrinology | ECE2022

A challenging case of sheehan syndrome

Rita Elvas Ana , Vieira Ine s , Melo Miguel , Rodrigues Di rcea , Gomes Maria Leonor , Paiva Isabel

Introduction: Sheehan Syndrome (SS) is a cause of hypopituitarism resulting from postpartum pituitary infarction. Its frequency is decreasing worldwide, particularly in developed countries due to advances in obstetric care. Case report: A 50-year-old female patient was admitted to the emergency department with complains of progressive pain in the lower hemithorax and abdomen. She also referred constipation, weight gain and asthenia. The initial laborator...

ea0081ep810 | Pituitary and Neuroendocrinology | ECE2022

Hypopituitarism in adults - the importance of clinical suspicion

Rita Elvas Ana , Lavrador Mariana , Melo Miguel , Barros Lui sa , Gomes Maria Leonor , Paiva Isabel

Introduction: Hypopituitarism is a rare entity that can have different aetiologies. Symptoms are usually progressive and non-specific; therefore, many patients are underdiagnosed and untreated. We present a clinical case of a patient presenting septic shock, hyponatremia and central hypothyroidism.Case report: A 46-year-old man was admitted in ICU for septic shock of unknown origin and multiorgan failure. Hormonal profile showed central hypothyroidism, p...

ea0090p692 | Pituitary and Neuroendocrinology | ECE2023

Characterisation of the clinical and biologic behaviour of acromegaly caused by pluri-hormonal tumours in a cohort of 75 patients

Martins Ferreira Mafalda , Carreira Ana , Cardoso Luis , Oliveira Patricia , Melo Miguel , Paiva Isabel

Introduction: The clinical and biochemical spectrum of pituitary acromegaly is wide and variable. There are pure somatotroph tumors(ST), immunohistochemically positive only for GH, and pluri-hormonal(PL), also positive for other hormones, and they appear to have different presentations and responses to treatment.Aims: To compare the clinical presentation, imaging characteristics and response to treatment of acromegalic patients according to the pituitary...

ea0090p267 | Late-Breaking | ECE2023

Surgical outcomes in acromegaly: The influence of sex and menopause

Carreira Ana , Martins Ferreira Mafalda , Cardoso Luis , Guelho Daniela , Gomes Leonor , Melo Miguel , Paiva Isabel

Introduction: Oestrogens and androgens modulate the effects of growth hormone (GH). Sex differences have been described in acromegaly, with conflicting results in different populations. Additionally, data on sex differences in tumour histopathology are scarce.Aims: To analyse the influence of sex and menopause status in tumour characteristics and surgical outcomes in patients with acromegaly.Materials and methods: Retrospective coh...

ea0049gp35 | Bone & Calcium Homeostasis 1 | ECE2017

Aldosterone and parathyroid hormone – is there a connection?

Ventura Mara , Melo Miguel , Oliveira Diana , Martins Diana , Lages Adriana , Cunha Nelson , Carrilho Francisco

Introduction: Recent studies seem to support a bidirectional positive interaction between aldosterone and parathyroid hormone (PTH). Understanding the normal physiological relationship between renin-angiotensin-aldosterone system (RAAS) and PTH is of clinical interest because their inappropriate activity may negatively impact cardiovascular and skeletal health.Objective: To evaluate the presence of an interaction between aldosterone and PTH in a cohort o...

ea0041ep818 | Obesity | ECE2016

Metabolically healthy obesity: exploring the paradox

Ventura Mara , Lages Adriana , Rodrigues Dircea , Oliveira Patricia , Melo Miguel , Martins Diana , Oliveira Diana , Carrilho Francisco

Introduction: Obesity is a chronic disease associated with multiple comorbidities, defined by BMI, without considering the metabolic state of the patient. There are few data on the proportion of obese patients without metabolic syndrome (MS).Objective: To characterize patients considered to be metabolically healthy (MH) followed at the obesity outpatient clinic of one University Hospital, and to compare this group with a group of obese patients with MS.<...

ea0041ep985 | Thyroid (non-cancer) | ECE2016

Clinical, imaging and cytological differences between palpable and non-palpable thyroid nodules

Silva Joao , Paiva Sandra , Ribeiro Cristina , Melo Miguel , Gomes Leonor , Bastos Margarida , Carrilho Francisco

Introduction: The prevalence of palpable nodules varies between 3–7% and nodules diagnosed by ultrasonography between 20–76%. According to the American Thyroid Association’s guidelines it isn’t recommended to perform routine thyroid ultrasound for thyroid nodules diagnosis, unless they are palpable or there are any risk factors.Objective: Evaluation of sonographic and cytological differences between palpable and non-palpable thyroid n...